Hytrinex en es it fr

Hytrinex Brand names, Hytrinex Analogs

Hytrinex Brand Names Mixture

  • No information avaliable

Hytrinex Chemical_Formula

C19H25N5O4

Hytrinex RX_link

http://www.rxlist.com/cgi/generic/teraz.htm

Hytrinex fda sheet

Hytrinex FDA

Hytrinex msds (material safety sheet)

Hytrinex Synthesis Reference

M. Winn et al., U.S. Pat. 4,026,894 (1977)

Hytrinex Molecular Weight

387.433 g/mol

Hytrinex Melting Point

273 oC

Hytrinex H2O Solubility

29.7mg/mL

Hytrinex State

Solid

Hytrinex LogP

0.875

Hytrinex Dosage Forms

Tablet

Hytrinex Indication

For the treatment of symptomatic benign prostatic hyperplasia (BPH) and also for hypertension.

Hytrinex Pharmacology

Terazosin, classified as a quinazoline, is similar to doxazosin and prazosin. As an alpha-adrenergic blocking agent, terazosin is used to treat hypertension and benign prostatic hypertrophy (BPH). Terazosin produces vasodilation and reduces peripheral resistance but in general has slight effect on cardiac output. Antihypertensive effect with chronic dosing is usually not accompanied by reflex tachycardia.

Hytrinex Absorption

Essentially completely absorbed in man (90% bioavailability).

Hytrinex side effects and Toxicity

LD50=259.3mg/kg (i.v. in mice)

Hytrinex Patient Information

Hytrinex Organisms Affected

Humans and other mammals